17Feb 2025
Once-Weekly Insulin Icodec Shows Consistent Efficacy Across Kidney Function Levels

Once-Weekly Insulin Icodec Shows Consistent Efficacy Across Kidney Function Levels

A post hoc analysis of ONWARDS 1–5 assessed insulin icodec versus daily basal insulins in type 2 diabetes patients by kidney function. Results from 3763 participants showed consistent HbA1c reductions and hypoglycemia outcomes across kidney function subgroups. No significant differences were noted in weight change or insulin dose trends, confirming icodec's efficacy across varying kidney functions.

  • #endo-diabetology

Like

Save

Share